항균 요도 카테터 시장 규모, 점유율, 동향 분석 : 제품별, 재료별, 코팅별, 카테터 삽입 기간별, 성별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Antimicrobial Urinary Catheters Market Summary

The global antimicrobial urinary catheters market size was estimated at USD 1.20 billion in 2025 and is projected to reach USD 2.27 billion by 2033, growing at a CAGR of 8.46% from 2026 to 2033. The market is primarily driven by the rising incidence of catheter-associated urinary tract infections (CAUTIs), which has increased demand for infection-prevention solutions in hospitals and home-care settings.

The growing prevalence of chronic conditions such as spinal cord injuries, urinary retention, and neurogenic bladder further supports catheter usage. Furthermore, heightened awareness of hospital-acquired infections, strict regulatory guidelines, and technological advancements such as silver-coated and antibiotic-impregnated catheters are accelerating market growth.

The rising incidence of CAUTIs is a key factor driving the market, as healthcare providers prioritize infection prevention and patient safety. Frequent complications related to CAUTIs, extended hospital stays, and higher treatment costs have accelerated the adoption of antimicrobial-coated and antibiotic-impregnated catheters. Furthermore, growing regulatory focus on reducing hospital-acquired infections and improving clinical outcomes is encouraging hospitals and home-care settings to shift toward advanced antimicrobial catheter solutions.

This directly supports the growing demand for antimicrobial urinary catheters, as hospitals and long-term care facilities adopt advanced catheter technologies to reduce CAUTI rates, improve patient outcomes, and minimize the overall economic burden of infection-related healthcare costs.

Global Antimicrobial Urinary Catheters Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global antimicrobial urinary catheters market report based on product, material, coating, catheterization, gender, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Intermittent Catheters
• Foley/Indwelling Catheters
• External Catheters
• Material Outlook (Revenue, USD Million, 2021 - 2033)
• Latex-Based
• Silicone-Based
• PVC/Vinyl
• Coating Outlook (Revenue, USD Million, 2021 - 2033)
• Silver-Based Coatings
• Antibiotic-Impregnated
• Hydrophilic Coatings
• Others
• Catheterization Outlook (Revenue, USD Million, 2021 - 2033)
• Long-Term
• Short-Term
• Gender Outlook (Revenue, USD Million, 2021 - 2033)
• Male
• Female
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals (ICU/Acute Care)
• Long-Term Care (Nursing Homes)
• Home Care Setting
• Ambulatory Surgical Centers
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Product
  • 1.1.2. Material
  • 1.1.3. Coating
  • 1.1.4. Catheterization
  • 1.1.5. Gender
  • 1.1.6. End Use
  • 1.1.7. Regional scope
  • 1.1.8. Estimates and forecast timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
  • 1.5.1. Data for primary interviews in North America
  • 1.5.2. Data for primary interviews in Europe
  • 1.5.3. Data for primary interviews in Asia Pacific
  • 1.5.4. Data for primary interviews in Latin America
  • 1.5.5. Data for Primary interviews in MEA
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
  • 1.7.2. Volume price analysis (Model 2)
    • 1.7.2.1. Approach 2: Volume price analysis
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Antimicrobial Urinary Catheters Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Rising prevalence of CAUTIs
    • 3.2.1.2. Focus on reducing hospital costs associated with infections
    • 3.2.1.3. Advancements in catheter technology
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. High cost of antimicrobial catheters
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Rising adoption in emerging markets
    • 3.2.3.2. Expanding home healthcare and long-term care settings
    • 3.2.3.3. Advancements in Antimicrobial Coating Technologies
    • 3.2.3.4. Expanding Geriatric Population & Chronic Conditions
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Regulatory hurdles
• 3.3. Antimicrobial Urinary Catheters Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal landscape

Chapter 4. Antimicrobial Urinary Catheters Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Antimicrobial Urinary Catheters Market: Product Movement Analysis, 2025 & 2033 (USD Million)
• 4.3. Global Antimicrobial Urinary Catheters Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Intermittent Catheters
  • 4.4.1. Intermittent catheters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 4.5. Foley/Indwelling Catheters
  • 4.5.1. Foley/indwelling catheters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 4.6. External Catheters
  • 4.6.1. External catheters market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Antimicrobial Urinary Catheters Market: Material Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Antimicrobial Urinary Catheters Market: Material Movement Analysis, 2025 & 2033 (USD Million)
• 5.3. Global Antimicrobial Urinary Catheters Market Size & Trend Analysis, by Material, 2021 to 2033 (USD Million)
• 5.4. Latex-Based
  • 5.4.1. Latex-based market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 5.5. Silicone-Based
  • 5.5.1. Silicone-based market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 5.6. PVC/Vinyl
  • 5.6.1. PVC/vinyl market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Antimicrobial Urinary Catheters Market: Coating Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Antimicrobial Urinary Catheters Market: Coating Movement Analysis, 2025 & 2033 (USD Million)
• 6.3. Global Antimicrobial Urinary Catheters Market Size & Trend Analysis, by Coating, 2021 to 2033 (USD Million)
• 6.4. Silver-Based Coatings
  • 6.4.1. Silver-based coatings market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 6.5. Antibiotic-Impregnated
  • 6.5.1. Antibiotic-impregnated market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 6.6. Hydrophilic Coatings
  • 6.6.1. Hydrophilic coatings market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 6.7. Others
  • 6.7.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Antimicrobial Urinary Catheters Market: Catheterization Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Antimicrobial Urinary Catheters Market: Catheterization Movement Analysis, 2025 & 2033 (USD Million)
• 7.3. Global Antimicrobial Urinary Catheters Market Size & Trend Analysis, by Catheterization, 2021 to 2033 (USD Million)
• 7.4. Long-Term
  • 7.4.1. Long-term market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 7.5. Short-Term
  • 7.5.1. Short-term market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Antimicrobial Urinary Catheters Market: Gender Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Global Antimicrobial Urinary Catheters Market: Gender Movement Analysis, 2025 & 2033 (USD Million)
• 8.3. Global Antimicrobial Urinary Catheters Market Size & Trend Analysis, by Gender, 2021 to 2033 (USD Million)
• 8.4. Male
  • 8.4.1. Male market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 8.5. Female
  • 8.5.1. Female market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Antimicrobial Urinary Catheters Market: End Use Estimates & Trend Analysis

• 9.1. Segment Dashboard
• 9.2. Global Antimicrobial Urinary Catheters Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
• 9.3. Global Antimicrobial Urinary Catheters Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 9.4. Hospitals (ICU/Acute Care)
  • 9.4.1. Hospitals (ICU/acute care) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 9.5. Long-Term Care (Nursing Homes)
  • 9.5.1. Long-term care (Nursing Homes) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 9.6. Home Care Setting
  • 9.6.1. Home healthcare market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 9.7. Ambulatory Surgical Centers
  • 9.7.1. Ambulatory surgical centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 10. Antimicrobial Urinary Catheters Market: Regional Estimates & Trend Analysis by Product, Material, Coating, Catheterization, Gender, and End Use

• 10.1. Regional Dashboard
• 10.2. Market Size and Trend Analysis, 2021 to 2033
• 10.3. North America
  • 10.3.1. North America antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.3.2. U.S.
    • 10.3.2.1. Key country dynamics
    • 10.3.2.2. Competitive scenario
    • 10.3.2.3. Regulatory framework
    • 10.3.2.4. Reimbursement scenario
    • 10.3.2.5. U.S. antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.3.3. Canada
    • 10.3.3.1. Key country dynamics
    • 10.3.3.2. Competitive scenario
    • 10.3.3.3. Regulatory framework
    • 10.3.3.4. Reimbursement scenario
    • 10.3.3.5. Canada antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.3.4. Mexico
    • 10.3.4.1. Key country dynamics
    • 10.3.4.2. Competitive scenario
    • 10.3.4.3. Regulatory framework
    • 10.3.4.4. Reimbursement scenario
    • 10.3.4.5. Mexico antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)
• 10.4. Europe
  • 10.4.1. Europe antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.4.2. UK
    • 10.4.2.1. Key country dynamics
    • 10.4.2.2. Competitive scenario
    • 10.4.2.3. Regulatory framework
    • 10.4.2.4. Reimbursement scenario
    • 10.4.2.5. UK antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.4.3. Germany
    • 10.4.3.1. Key country dynamics
    • 10.4.3.2. Competitive scenario
    • 10.4.3.3. Regulatory framework
    • 10.4.3.4. Reimbursement scenario
    • 10.4.3.5. Germany antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.4.4. France
    • 10.4.4.1. Key country dynamics
    • 10.4.4.2. Competitive scenario
    • 10.4.4.3. Regulatory framework
    • 10.4.4.4. Reimbursement scenario
    • 10.4.4.5. France antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.4.5. Italy
    • 10.4.5.1. Key country dynamics
    • 10.4.5.2. Competitive scenario
    • 10.4.5.3. Regulatory framework
    • 10.4.5.4. Reimbursement scenario
    • 10.4.5.5. Italy antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.4.6. Spain
    • 10.4.6.1. Key country dynamics
    • 10.4.6.2. Competitive scenario
    • 10.4.6.3. Regulatory framework
    • 10.4.6.4. Reimbursement scenario
    • 10.4.6.5. Spain antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.4.7. Sweden
    • 10.4.7.1. Key country dynamics
    • 10.4.7.2. Competitive scenario
    • 10.4.7.3. Regulatory framework
    • 10.4.7.4. Reimbursement scenario
    • 10.4.7.5. Sweden antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.4.8. Denmark
    • 10.4.8.1. Key country dynamics
    • 10.4.8.2. Competitive scenario
    • 10.4.8.3. Regulatory framework
    • 10.4.8.4. Reimbursement scenario
    • 10.4.8.5. Denmark antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.4.9. Norway
    • 10.4.9.1. Key country dynamics
    • 10.4.9.2. Competitive scenario
    • 10.4.9.3. Regulatory framework
    • 10.4.9.4. Reimbursement scenario
    • 10.4.9.5. Norway antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)
• 10.5. Asia Pacific
  • 10.5.1. Asia Pacific antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.5.2. China
    • 10.5.2.1. Key country dynamics
    • 10.5.2.2. Competitive scenario
    • 10.5.2.3. Regulatory framework
    • 10.5.2.4. Reimbursement scenario
    • 10.5.2.5. China antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.5.3. Japan
    • 10.5.3.1. Key country dynamics
    • 10.5.3.2. Competitive scenario
    • 10.5.3.3. Regulatory framework
    • 10.5.3.4. Reimbursement scenario
    • 10.5.3.5. Japan antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.5.4. India
    • 10.5.4.1. Key country dynamics
    • 10.5.4.2. Competitive scenario
    • 10.5.4.3. Regulatory framework
    • 10.5.4.4. Reimbursement scenario
    • 10.5.4.5. India antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.5.5. South Korea
    • 10.5.5.1. Key country dynamics
    • 10.5.5.2. Competitive scenario
    • 10.5.5.3. Regulatory framework
    • 10.5.5.4. Reimbursement scenario
    • 10.5.5.5. South Korea antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.5.6. Australia
    • 10.5.6.1. Key country dynamics
    • 10.5.6.2. Competitive scenario
    • 10.5.6.3. Regulatory framework
    • 10.5.6.4. Reimbursement scenario
    • 10.5.6.5. Australia antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.5.7. Thailand
    • 10.5.7.1. Key country dynamics
    • 10.5.7.2. Competitive scenario
    • 10.5.7.3. Regulatory framework
    • 10.5.7.4. Reimbursement scenario
    • 10.5.7.5. Thailand antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)
• 10.6. Latin America
  • 10.6.1. Latin America antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.6.2. Brazil
    • 10.6.2.1. Key country dynamics
    • 10.6.2.2. Competitive scenario
    • 10.6.2.3. Regulatory framework
    • 10.6.2.4. Reimbursement scenario
    • 10.6.2.5. Brazil antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.6.3. Argentina
    • 10.6.3.1. Key country dynamics
    • 10.6.3.2. Competitive scenario
    • 10.6.3.3. Regulatory framework
    • 10.6.3.4. Reimbursement scenario
    • 10.6.3.5. Argentina antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)
• 10.7. Middle East and Africa
  • 10.7.1. Middle East and Africa antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.7.2. South Africa
    • 10.7.2.1. Key country dynamics
    • 10.7.2.2. Competitive scenario
    • 10.7.2.3. Regulatory framework
    • 10.7.2.4. Reimbursement scenario
    • 10.7.2.5. South Africa antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.7.3. Saudi Arabia
    • 10.7.3.1. Key country dynamics
    • 10.7.3.2. Competitive scenario
    • 10.7.3.3. Regulatory framework
    • 10.7.3.4. Reimbursement scenario
    • 10.7.3.5. Saudi Arabia antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.7.4. UAE
    • 10.7.4.1. Key country dynamics
    • 10.7.4.2. Competitive scenario
    • 10.7.4.3. Regulatory framework
    • 10.7.4.4. Reimbursement scenario
    • 10.7.4.5. UAE antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 10.7.5. Kuwait
    • 10.7.5.1. Key country dynamics
    • 10.7.5.2. Competitive scenario
    • 10.7.5.3. Regulatory framework
    • 10.7.5.4. Reimbursement scenario
    • 10.7.5.5. Kuwait antimicrobial urinary catheters market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 11. Competitive Landscape

• 11.1. Recent Developments & Impact Analysis by Key Market Participants
• 11.2. Company Categorization
• 11.3. Company Market Share Analysis, 2025
• 11.4. Company Heat Map Analysis
• 11.5. Strategy Mapping
  • 11.5.1. Expansion
  • 11.5.2. Mergers & Acquisition
  • 11.5.3. Partnerships & Collaborations
  • 11.5.4. New Product Launches
  • 11.5.5. Research And Development
  • 11.5.6. Company Profiles
  • 11.5.7. BD (Bactigaurd)
    • 11.5.7.1. Company overview
    • 11.5.7.2. Financial performance
    • 11.5.7.3. Product Benchmarking
    • 11.5.7.4. Strategic initiatives
  • 11.5.8. MEDLINE
    • 11.5.8.1. Company overview
    • 11.5.8.2. Financial performance
    • 11.5.8.3. Product Benchmarking
    • 11.5.8.4. Strategic initiatives
  • 11.5.9. ConvaTec Group PLC
    • 11.5.9.1. Company overview
    • 11.5.9.2. Financial performance
    • 11.5.9.3. Product Benchmarking
    • 11.5.9.4. Strategic initiatives
  • 11.5.10. WellLead Medical Co., Ltd.
    • 11.5.10.1. Company overview
    • 11.5.10.2. Financial performance
    • 11.5.10.3. Product Benchmarking
    • 11.5.10.4. Strategic initiatives
  • 11.5.11. Silq Technologies
    • 11.5.11.1. Company overview
    • 11.5.11.2. Financial performance
    • 11.5.11.3. Product Benchmarking
    • 11.5.11.4. Strategic initiatives
  • 11.5.12. AvantGuard (Halomine Inc.)
    • 11.5.12.1. Company overview
    • 11.5.12.2. Financial performance
    • 11.5.12.3. Product Benchmarking
    • 11.5.12.4. Strategic initiatives